• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of advisory committee members participating in meetings in the month who were granted waivers

FY 2010 Target: Less than 13.04%

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the member's expertise is considered essential to the committee’s discussions and recommendations. FDA must also take into consideration a cap on the number of waivers that can be granted each year. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, many of the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of September 30, 2013.

Fiscal Year - 2010

Skip graphic and jump to text data

FY 2010 Target: Less than 13.04%

TimeTargetPercent Granted Waivers
Oct 200913.044
Nov 200913.042
Dec 200913.041
Jan 201013.040
Feb 201013.040
Mar 201013.042
Apr 201013.040
May 201013.041
Jun 201013.040
Jul 201013.041
Aug 201013.040
Sep 201013.040

FY 2010 Overall: 1%

Total number of advisory committee members participating in meetings in the month who were granted waivers

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetWaivers Granted
Oct 2009N/A4
Nov 2009N/A3
Dec 2009N/A1
Jan 2010N/A0
Feb 2010N/A0
Mar 2010N/A4
Apr 2010N/A0
May 2010N/A1
Jun 2010N/A0
Jul 2010N/A1
Aug 2010N/A0
Sep 2010N/A0

FY 2010 Total: 14

Total number of advisory committee members participating in meetings in the month

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetCommittee Members
Oct 2009N/A111
Nov 2009N/A131
Dec 2009N/A192
Jan 2010N/A32
Feb 2010N/A55
Mar 2010N/A190
Apr 2010N/A96
May 2010N/A94
Jun 2010N/A81
Jul 2010N/A163
Aug 2010N/A63
Sep 2010N/A115

FY 2010 Total: 1,323

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.